🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users administering products of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and customer laws, risking fines, legal action or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has removed problematic material and prohibited related keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, positive reviews and detailed instructions for preparing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Item Details and Pricing

Inside these communities, posts display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly serious medical dangers”.